ArticleAntimicrobial agents and chemotherapy2003

In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.

Patricia M Roblin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.